Noninvasive Ventilation for Critical Care* Erik Garpestad, MD, FCCP; John Brennan, MD; and Nicholas S. Hill, MD, FCCP
|
|
- Derek Andrews
- 6 years ago
- Views:
Transcription
1 CHEST Noninvasive Ventilation for Critical Care* Erik Garpestad, MD, FCCP; John Brennan, MD; and Nicholas S. Hill, MD, FCCP Postgraduate Education Corner CONTEMPORARY REVIEWS IN CRITICAL CARE MEDICINE Noninvasive ventilation (NIV), the provision of ventilatory assistance without an artificial airway, has emerged as an important ventilatory modality in critical care. This has been fueled by evidence demonstrating improved outcomes in patients with respiratory failure due to COPD exacerbations, acute cardiogenic pulmonary edema, or immunocompromised states, and when NIV is used to facilitate extubation in COPD patients with failed spontaneous breathing trials. Numerous other applications are supported by weaker evidence. A trial of NIV is justified in patients with acute respiratory failure due to asthma exacerbations and postoperative states, extubation failure, hypoxemic respiratory failure, or a do-not-intubate status. Patients must be carefully selected according to available guidelines and clinical judgment, taking into account risk factors for NIV failure. Patients begun on NIV should be monitored closely in an ICU or other suitable setting until adequately stabilized, paying attention not only to vital signs and gas exchange, but also to comfort and tolerance. Patients not having a favorable initial response to NIV should be considered for intubation without delay. NIV is currently used in only a select minority of patients with acute respiratory failure, but with technical advances and new evidence on its proper application, this role is likely to further expand. (CHEST 2007; 132: ) Key words: acute respiratory failure; COPD; mechanical ventilation; noninvasive ventilation Abbreviations: ALI acute lung injury; APACHE acute physiology and chronic health evaluation; CHF congestive heart failure; CI confidence interval; CPAP continuous positive airway pressure; CPE cardiogenic pulmonary edema; DNI do not intubate; Fio 2 fraction of inspired oxygen; NIV noninvasive ventilation; PEEP positive end-expiratory pressure One of the most important developments in the field of mechanical ventilation over the past 15 years has been the emergence of noninvasive ventilation (NIV) as an increasing part of the critical care armamentarium. Although similar techniques such *From the Division of Pulmonary, Critical Care, and Sleep Medicine, Tufts-New England Medical Center, Boston, MA. Dr. Hill has received honoraria and research grants from and served on the medical advisory boards of ResMed, Inc., and Respironics, Inc. He has received a research grant from Versamed, Inc. Drs. Garpestad and Brennan have no conflicts of interest to disclose. Manuscript received October 28, 2006; revision accepted March 12, Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( org/misc/reprints.shtml). Correspondence to: Nicholas S. Hill, MD, FCCP, Division of Pulmonary, Critical Care and Sleep Medicine, Tufts-New England Medical Center, 750 Washington St, Boston, MA 02111; nhill@tufts-nemc.org DOI: /chest as intermittent positive pressure breathing were used widely during previous decades, unlike NIV they were used mainly to provide intermittent aerosol therapy. The term NIV includes other forms of ventilatory assistance that avoid airway invasion, such as negative pressure ventilation, but the vast majority of NIV applications now use positive pressure. Noninvasive application of continuous positive airway pressure (CPAP) will be considered a form of NIV here when used to treat certain types of respiratory failure, but it is not a true form of ventilatory assistance because the positive pressure does not increase intermittently to assist inspiration. The emergence of NIV has been fueled by its relative ease of application compared to alternative forms of noninvasive ventilation, as well as its demonstrated ability to improve patient outcomes in certain forms of acute respiratory failure compared to previously standard therapy, including endotra- CHEST / 132 / 2/ AUGUST,
2 cheal intubation. 1 This update will focus on recent developments regarding acute applications of NIV, including the expanding evidence base, technical advances, and assessment of current utilization. We emphasize techniques for proper patient selection and implementation that are critical if success rates reported in the literature are to be duplicated. NIV for Acute Respiratory Failure Recommended Indications Many applications of NIV have been tried in the critical care setting, but as of yet, only four are supported by multiple randomized controlled trials and metaanalyses. COPD Exacerbations The strongest level of evidence, including multiple randomized controlled trials, 2 7 supports the use of NIV to treat exacerbations of COPD. Also, metaanalyses by Ram et al 8 and Keenan et al 9 demonstrate more rapid improvements in vital signs and gas exchange as well as reductions in the need for intubation (relative risk, 0.41; 95% confidence interval [CI], 0.33 to 0.53; risk reduction, 28%), decreased mortality (relative risk, 0.52; 95% CI, 0.35 to 0.76; risk reduction, 10%), and decreased hospital length of stay ( 3.24 days; 95% CI, 4.42 to 2.06 days and 4.57 days, respectively). The Cochrane analysis 8 also noted more rapid improvements in vital signs, ph, and gas exchange, and reduced complication rates and hospital lengths of stay. Based on these observations, NIV should now be considered the ventilatory modality of first choice to treat acute respiratory failure caused by exacerbations of COPD. Acute Cardiogenic Pulmonary Edema Similarly strong evidence supports the use of noninvasive positive pressure techniques to treat acute cardiogenic pulmonary edema (CPE) Recent metaanalyses on the use of NIV to treat acute pulmonary edema have shown that both CPAP and NIV lower intubation and mortality rates compared to conventional therapy with oxygen, although the reduction in mortality rate was statistically significant only in one of the metaanalyses. 20. A randomized trial 17 comparing CPAP directly to NIV showed no difference in outcomes between the two to treat CPE, a finding confirmed in a recent metaanalysis by Ho and Wong. 21 Accordingly, by virtue of its greater simplicity and lesser expense, CPAP has been suggested as the initial noninvasive choice for acute CPE. However, some studies 22 have observed more rapid improvements in gas exchange and vital signs with NIV than with CPAP alone, so NIV may be preferable for patients with persisting dyspnea or hypercapnia after initiation of CPAP. Facilitating Extubation in COPD Patients Another NIV application supported by multiple randomized trials is to facilitate extubation in COPD patients. Candidates for early extubation are those who were intubated for COPD exacerbations because they were poor candidates for or failed NIV initially and are unable to pass a T-piece trial even though they have improved sufficiently to tolerate NIV. Ferrer et al 23 confirmed earlier findings of Nava et al 24 in such patients, randomizing 43 patients with persistent weaning failure (failure of three consecutive T-piece trials) to be extubated to NIV or weaned using conventional methods. They observed that NIV-treated patients had shorter durations of intubation (9.5 days vs 20.1 days) and ICU (14 days vs 25 days) and hospital stays (14.6 days vs 40.8 days), decreased incidence of nosocomial pneumonia (24% vs 59%), and improved ICU and 90-day survivals (80% vs 50%) [all p 0.05]. These studies strongly support the use of NIV to facilitate extubation in patients with hypercapnic respiratory failure and to avoid the complications of prolonged intubation. But it must be applied cautiously: only in patients who are otherwise good candidates for NIV and were not difficult intubations. Immunocompromised Patients The use of NIV is also well supported for immunocompromised patients who are at high risk for infectious complications from endotracheal intubation, such as those with hematologic malignancies, AIDS, or following solid-organ or bone marrow transplants. In a randomized trial 25 of patients with hypoxemic respiratory failure following solid-organ transplantation, NIV use decreased intubation rate (20% vs 70%, p 0.002) and ICU mortality (20% vs 50%, p 0.05) compared with conventional therapy with oxygen. Hilbert et al 26 observed fewer intubations (46% vs 77%) and a lower mortality rate (50% vs 81%) [both p 0.05] among immunocompromised patients (mainly hematologic malignancies, but some after solid-organ transplantation or with AIDS) with acute respiratory failure randomized to NIV as opposed to conventional therapy. The sizable reductions in mortality in these studies strongly support the early use of NIV as the initial ventilatory modality in immunocompromised patients with acute respiratory failure, although morbidity and mortality rates are still likely to be high. 712 Postgraduate Education Corner
3 Conditions for Which NIV Should Be Considered These applications are supported by a single randomized controlled trial, historically controlled trials, or multiple trials yielding conflicting evidence. NIV can be tried if patients are selected and monitored carefully. Asthma Several uncontrolled series and one randomized trial 30 support the use of NIV for acute asthma. In the randomized trial, 30 a pilot, 33 patients with acute dyspnea but not in respiratory failure were randomized to standard therapy with nasal bilevel ventilation for3horstandard therapy with sham NIV. NIV improved expiratory flow rates more rapidly (80% of patients had a 50% increase in FEV 1 in the first hour, compared to only 20% in the sham group) and reduced the need for hospitalization. 30 The authors speculated that the positive pressure had a salutary effect on airway dilatation, although these results have yet to be replicated. A case report 31 raised concerns about the use of NIV for asthma, and a recent metaanalysis by Ram et al 32 concluded that routine use of NIV in severe acute asthma could not be recommended. We believe that a cautious trial should still be considered in asthmatics not responding to the first hour of conventional therapy, but more study is warranted. Postoperative Respiratory Failure Either NIV or CPAP may be helpful in averting postoperative respiratory failure by preventing atelectasis and/or improving gas exchange as suggested by three randomized controlled trials in patients undergoing different surgical procedures. Following thoracoabdominal aneurysm repair, prophylactic use of CPAP reduces overall pulmonary complications. 33 Squadrone et al 34 compared CPAP vs conventional oxygen therapy in patients with hypoxemic respiratory failure after major elective abdominal surgery. The CPAP group had lower rates of intubation, pneumonia, and sepsis. In the only randomized, controlled trial of NIV in postoperative patients, Auriant et al 35 found that NIV reduced intubation and mortality rates in patients with hypoxemic respiratory failure following lung resection. These trials indicate that either CPAP or NIV should be strongly considered to prevent or treat postoperative respiratory failure, mainly after lung resection in patients with underlying COPD or congestive heart failure (CHF). Although multiple studies support this application, further studies need to focus on the use of NIV following specific surgical procedures before firmer recommendations can be made. Do-Not-Intubate Patients Use of NIV for patients with acute respiratory failure who have a do-not-intubate (DNI) status has aroused debate. Concerns have been raised that the modality might merely prolong the dying process while mask discomfort outweighs any palliative effect. 36 However, a prospective observational study by Levy et al 37 showed that patients with reversible diagnoses such as COPD and CHF had a betterthan-even chance of surviving the hospitalization if treated with NIV (52% and 75%, respectively), whereas those with pneumonia or cancer had much lower likelihoods of hospital survival. Schettino et al 38 reported similar findings in their observational cohort and noted low success rates for NIV in postextubation respiratory failure, hypoxemic respiratory failure, and end-stage cancer. Some have proposed resolving the conflict about the use of NIV in DNI patients by specifying the goals of therapy. 39 Patients with reversible processes such as COPD exacerbations or CHF may wish to survive the acute illness and thus use NIV as a form of life support. They are willing to endure some discomfort to achieve this aim. Others desire palliation, aiming to alleviate dyspnea or briefly prolong survival to settle affairs. In these latter circumstances, excessive mask discomfort would justify stopping therapy because the goal of palliation is not being met. Differentiating between and agreeing on these aims requires close and effective communication between caregivers, patient and family. Hypoxemic Respiratory Failure Randomized controlled trials suggest that patients with hypoxemic respiratory failure (ie, severe respiratory distress, Pao 2 /fraction of inspired oxygen (Fio 2 ) 200 and a non-copd cause for respiratory failure) benefit from use of NIV. 40,41 In 105 such patients, Ferrer et al 41 found that compared to conventional therapy, NIV reduced the intubation rate (52 to 25%), the incidence of septic shock (31 to 12%) and ICU mortality (39 to 18%), and improved 90-day mortality (all p 0.05). Notably, almost one third of the patients had CPE, which would be expected to respond favorably to NIV, but patients with pneumonia were the ones that benefited the most in this study. This latter finding contrasts with earlier trials that showed an association between pneumonia and NIV failure and the need for intubation in approximately two thirds of patients with pneumonia treated initially with NIV. 45 One randomized controlled trial 46 studying patients with severe communityacquired pneumonia showed that NIV improved outcomes including survival at 2 months but only in CHEST / 132 / 2/ AUGUST,
4 patients with underlying COPD. In one prospective cohort study, 47 risk factors for NIV failure in patients with acute hypoxemic respiratory failure included the diagnoses of ARDS or severe community-acquired pneumonia, more severe hypoxemia (Pao 2 / Fio after the first hour of treatment), and age 40 years. In another study 48 of NIV to treat hypoxemic respiratory failure, shock, severe hypoxemia, and severe metabolic acidosis were associated with poor outcomes. In a prospective analysis 49 of selected patients with acute lung injury (ALI)/ARDS treated with NIV as the initial ventilator modality, a simplified acute physiology score II 34 and a Pao 2 /Fio after 1 h of therapy predicted failure. The outcome of NIV is also very poor when used to treat hypoxemic respiratory failure in patients with idiopathic pulmonary fibrosis, 48 and this application should be discouraged. A concern that must be stressed is that the diagnostic category of hypoxemic respiratory failure is very broad and benefits accruing to certain subsets of patients within the larger diagnostic category could obscure adverse consequences in smaller subgroups. Thus, with the exception of use for CPE, which is supported by strong evidence, NIV should be used only with caution in carefully selected patients with hypoxemic respiratory failure, and those at high risk for failure should be considered for early intubation, especially if oxygenation fails to improve substantially within the first hour or two (Fig 1). Extubation Failure The use of NIV to prevent or treat extubation failure has also raised concerns. Respiratory failure following extubation imparts a poor prognosis; the duration of mechanical ventilation is lengthened, the likelihood of discharge to a chronic care facility is increased, and mortality may reach 40%. 50 Esteban et al 51 evaluated the ability of NIV to avoid extubation failure by randomizing patients to NIV or conventional therapy if risk factors developed, including hypercapnea, hypoxemia, acidemia, or tachypnea, after a routine extubation. Surprisingly, NIV not only failed to lower the reintubation rate compared to conventional therapy (approximately 50% in both groups) but it also increased ICU mortality. This was thought to be related to delayed reintubations in the NIV group, an average of 10 h later than in the conventional therapy group. The authors 51 concluded that NIV is not effective in averting the need for reintubation in unselected patients in whom respiratory failure develops after extubation and that it may in fact be harmful. However, only 10% of the enrolled patients had COPD. Also, approximately 25% of the conventional therapy group was crossed over to NIV when they met criteria for respiratory failure, and only 25% of these patients required reintubation. Thus, results of the study 51 do not apply to COPD patients and suggest that rather than initiating NIV early in patients deemed at risk for postextubation failure, one should wait until there are clear indications for NIV so that appropriate patients can be selected. Two subsequent trials support these latter inferences. Ferrer et al 52 identified patients at risk for postextubation failure by virtue of age 65 years, a history of CHF, or an APACHE (acute physiology and chronic health evaluation) II score 12. Although postextubation respiratory failure and need for intubation were significantly reduced by NIV overall, most of the benefit was attributable to the hypercapnic subgroup, amounting to about one third of the patients, who also had a significantly lower mortality rate than control subjects (4% vs 41%, p 0.05). Nava et al 53 used NIV in patients at high risk for extubation failure, using criteria similar to those of Esteban et al, 51 but risk was higher because patients had to have failed at least one T-piece trial. Once again, the need for reintubation (8% vs 18%, p 0.027) was reduced compared to the conventional therapy group. Also, ICU mortality was 10% less in the NIV group (p 0.01) mediated by the reduced need for reintubation. Thus, a trial of NIV appears to be warranted in patients at high risk for extubation failure, particularly if they have hypercapnic respiratory failure. Selection of Patients for NIV Selection of appropriate patients is crucial for the optimization of NIV success rates and resource utilization. Often, NIV must be started before laboratory data are available because patients may deteriorate during the delay and increase the risk of NIV failure. As depicted in Figure 1, patients with respiratory distress and an appropriate diagnosis should be considered for NIV. At the bedside, the clinician must make two fundamental judgments: (1) whether the patient needs ventilatory assistance based on symptoms and signs of increased work of breathing or arterial blood gas derangements, and (2) whether such patients are candidates for NIV or should be promptly intubated. These determinations are key to the appropriate application and outcome of NIV and are based on the diagnosis, bedside observations, the clinician s experience, and consideration of available guidelines (Table 1). The timing of NIV initiation is important too. NIV should be started early, as soon 714 Postgraduate Education Corner
5 Figure 1. Algorithm illustrating the principles of patient selection and practical application of NIV. Patients are started on NIV if respiratory distress develops in the setting of de novo or acute-on-chronic respiratory failure, or following surgery or extubation. They should have an appropriate diagnosis and meet guidelines demonstrating the need for ventilatory assistance and absence of contraindications. After starting NIV, they should be closely monitored and checked at 1 to 2 h to establish that they are responding favorably. If they have ALI/ARDS and are not good candidates, have contraindications or fail the 1- to 2-h checkpoint, they should be intubated unless they have a DNI status, in which case some patients might still benefit from palliation of respiratory distress. NIV to facilitate weaning should be considered for intubated patients. Patients who respond favorably to NIV should be monitored closely and reassessed periodically to determine whether they are ready to attempt weaning, which is usually accomplished by temporary discontinuation. If they have persisting respiratory failure after temporary discontinuation, long-term nocturnal NIV should be considered. CHEST / 132 / 2/ AUGUST,
6 Table 1 Selection Guidelines for NIV in the Acute Setting Appropriate diagnosis with potential reversibility Establish need for ventilatory assistance Moderate-to-severe respiratory distress and Tachypnea (respiratory rate 24/min for COPD, 30/min for CHF); accessory muscle use or abdominal paradox Blood gas derangement (ph 7.35, Paco 2 45 mm Hg, or Pao 2 /Fio 2 200) Exclude patients with contraindications to NIV Respiratory or cardiac arrest Medical instability (hypotensive shock, myocardial infarction requiring intervention, uncontrolled ischemia or arrhythmias) Unable to protect airway Unable to fit mask Untreated pneumothorax Recent upper airway or esophageal surgery Excessive secretions* Uncooperative or agitated* *Relative contraindications. as indications appear, because delay may permit further deterioration and increase the likelihood of failure. 54 Coma has been considered a contraindication to NIV in the past, but in a prospective cohort study, Gonzalez Diaz et al 55 observed a high success rate of NIV in patients with hypercapnic coma. Also, Scala et al 56 showed in a case study that NIV may be successfully used in COPD patients with acute respiratory failure and altered consciousness, although more severely impaired consciousness was associated with higher failure rates. Predictors of NIV success or failure may also be helpful in selecting patients (Table 2). The best predictor of success is a favorable response to NIV within the first 2 h. In a prospective cohort study of nearly 800 COPD patients treated with NIV, Confalonieri et al 57 identified four factors APACHE II score, ph, respiratory rate, and Glasgow coma score that, when combined in a chart, showed good predictive value at baseline. These factors had even better predictive value after 2hofNIVuse; if all four factors were favorable, the chance of success was 97%; whereas if all were unfavorable, failure was a virtual certainty (99%). Antonelli et al 47 made similar observations in patients with hypoxemic respiratory failure: if Pao 2 / Fio 2 failed to increase 146 after the first hour of NIV therapy, or if the patient had pneumonia and ARDS, the risk of NIV failure was increased. These observations, combined with those of Esteban et al, 51 demonstrating worse outcomes in NIV-treated patients having delayed reintubations, emphasize the importance of carefully reassessing patients soon after NIV initiation (1- to 2-h checkpoint as depicted in Fig 1). If they fail to improve sufficiently, they Table 2 Factors Associated With NIV Success in the Acute Setting Synchronous breathing with ventilator Dentate Less air leaking Fewer secretions Good tolerance Respiratory rate 30/min* Lower APACHE II score ( 29)* ph 7.30* Glasgow coma score 15* Pao 2 /Fio after first hour if hypoxemic respiratory failure COPD, CPE No pneumonia, ARDS Best predictor of success is a good response to NPPV within 1 to 2h: Reduction in respiratory rate Improvement in ph Improvement in oxygenation Reduction in Paco 2 *If all four are present in COPD patients at baseline, the likelihood of success is 94%; if present after 2hoftherapy, the likelihood of success is 97%. 46 should be promptly intubated because a delay in needed intubation permits the development of a respiratory crisis, requiring emergent intubation and increasing the likelihood of morbidity or mortality. Interfaces Advances in Technology A well-fitting and comfortable interface (or mask) is crucial to the success of noninvasive ventilation. Although nasal masks have certain advantages over oronasal (or full face) masks including greater comfort, less likelihood of causing claustrophobia, and easier speech and expectoration, they also permit more air leakage through the mouth and have been associated with a higher rate of initial intolerance during acute applications of NIV. 58 Thus, oronasal masks are preferred initially for most critical care applications, although a nasal mask should still be considered for patients with claustrophobia or frequent expectoration or for long-term applications. Other mask types that are receiving attention include the Total Face Mask (Respironics; Murrysville, PA), which seals around the perimeter of the face and may enhance mask tolerance in some patients, and the helmet, which has not yet been approved by the Food and Drug Administration for NIV in the United States but has been investigated in Europe. 59,60 The latter device consists of a plastic cylinder that fits over the head and seals around the neck and shoulders. Compared to the full face mask in a case-control study 61 of NIV to treat COPD 716 Postgraduate Education Corner
7 patients with acute respiratory failure, the helmet achieved similar improvements in vital signs, equivalent intubation and mortality rates and caused fewer complications, but Paco 2 tended to be higher at the end of the treatment period despite a higher level of pressure support. Also, noise levels within the helmet may be as high as 100 decibels, compared to 70 decibels with a full-face mask. 62 Thus, although the helmet has some advantages over the full face mask with regard to comfort and complications, it has other disadvantages including less efficient CO 2 removal and noisiness that limit its current utility. Dead Space and Rebreathing By virtue of its single-ventilator-circuit design, bilevel ventilation has raised concerns about rebreathing. 63 A lung model study 64 demonstrated that masks with smaller volumes were associated with less rebreathing and an in-mask exhalation port minimized rebreathing compared to an in-line port. Another lung model study 65 used a mannequin face to demonstrate that an in-mask exhalation port over the bridge of the nose minimized dynamic dead space, sometimes to levels below physiologic, presumably by flushing CO 2 from the nose and mouth. The correlation between dynamic dead space and actual mask volume was poor, probably because of air streaming, and dead space was also minimized if positive expiratory pressure flushed CO 2 from the ventilator tubing. Whether these differences in dead space and rebreathing are clinically important remains unclear, but these studies support the use of in-mask exhalation ports and positive expiratory pressure during bilevel ventilation. Ventilators NIV is usually delivered either by blower-based portable positive pressure bilevel ventilators derived from home-based CPAP systems or critical care ventilators designed to deliver invasive mechanical ventilation. No study has shown better NIV success rates for one type of ventilator than the other, but the ventilator mode used and specific settings are important for patient comfort and decreased work of breathing. Pressure support ventilation is rated as more tolerable by patients than assist-control modes, 66 and some studies have demonstrated greater comfort with proportional assist ventilation than with pressure support, presumably because it is targeted to inspiratory flow as a surrogate of patient effort and can respond nearly instantaneously to changes in demand. Proportionalassist ventilation has only recently been approved by the Food and Drug Administration, but it has been available elsewhere in the world for almost a decade. The perceived need for multiple adjustments to compensate for patient elastance and resistance as well as added cost have probably limited greater use of this mode despite the finding in one of the controlled trials that proportional assist required fewer adjustments than pressure support. 68 Other desirable attributes of ventilators for NIV include the ability to compensate for air leaks, which helps to assure delivery of adequate tidal volumes. 70 Because NIV lowers humidity of delivered gas, humidification is useful to bring relative humidity back toward the ambient range, possibly enhancing comfort. 71 Heated passover humidifiers have minimal effects on delivered pressures, whereas heat and moisture exchangers are to be avoided because they can interfere with the ability of NIV to reduce work of breathing. 72 Ventilator Settings L Her et al 73 showed that patients with acute lung injury treated with NIV require pressure support levels of at least 10 to 15 cm H 2 O to reduce work of breathing. Not surprisingly, higher levels of positive end-expiratory pressure (PEEP) [10 cm H 2 Ovs5cm H 2 O] were more effective at improving oxygenation. Combining higher levels of pressure support with high-level PEEP can detract from patient comfort, however, so compromises may be necessary to optimize settings; maximal oxygenation may have to be sacrificed if patient comfort and reduction in work of breathing are prioritized. Many noninvasive ventilators now offer adjustable rise times or pressurization rates the time taken to achieve the target inspiratory pressure to optimize patient comfort. Prinianakis et al 74 found that a rapid pressurization rate was most effective at reducing work of breathing in COPD patients, but a slightly slower rate was associated with better comfort ratings. Guidelines, Utilization, and Outcomes Sinuff et al 75 found that a NIV guideline influenced caregiver behavior, leading to greater ICU utilization and more ordering of pulmonary consultations and arterial blood gases. However, overall mortality rate was unchanged and, of concern, the mortality rate actually increased in patients without COPD or CHF as the cause of their acute respiratory failure, who were excluded from NIV use by the guideline. The results highlight the need for ongoing guideline evaluation and modification because they could increase resource utilization and the cost of care if they mandate ICU use and frequent laboratory testing among all NIV patients, some of whom could conceivably be managed in less costly environments. CHEST / 132 / 2/ AUGUST,
8 Studies of NIV utilization in the acute care setting have found that enormous disparity exists between different institutions. In a 1997 survey of NIV use in European ICUs, Carlucci et al 76 found that 20% of ICUs surveyed used no NIV at all and, overall, NIV was used in 16% of all ventilator starts. A subsequent UK survey 77 found that 52% of hospitals were not using NIV. A more recent survey 78 in the United States found that although only 1 of 71 responding hospitals used no NIV, some used it in 5% of ventilator starts and others in 50%. Overall average use among ventilator starts was 20%, but only a third of patients with COPD or CHF received NIV as their initial ventilator therapy. Major reasons for not using NIV more were lack of physician knowledge and inadequately trained staff, suggesting that education may help to enhance utilization. However, progress is being made, as indicated by Demoule et al, 79 who found that the overall percentage for NIV among ventilator starts in European ICUs had risen to 23% by 2002; and Girou et al, 80 who showed that increasing use of NIV in CHF and COPD patients (from approximately 20 to 90% of ventilator starts) over a 7-year period in a French ICU was associated with a decrease in the rate of nosocomial pneumonias from 20 to 8% and in ICU mortality rate from 21 to 7% (all p 0.05). The latter study 80 also illustrates the value of increasing experience using NIV after establishing an NIV program. Conclusion The role of NIV in the management of acute respiratory failure has been further clarified in recent years. Evidence is strong to support the use of NIV in the initial management of acute respiratory failure in patients with COPD exacerbations, acute CPE, and immunocompromised states, and to facilitate extubation in patients with COPD with failed spontaneous breathing trials. A trial of NIV is justified in patients with asthma exacerbations, postoperative respiratory failure, extubation failure, hypoxemic respiratory failure or a DNI status, but because supporting evidence is not as strong, they should be carefully selected according to available guidelines and clinical judgment, taking into account risk factors for NIV failure. Once begun, patients should be closely monitored in an ICU or step-down unit until adequately stabilized, paying attention not only to vital signs and gas exchange, but also to comfort and tolerance. If patients do not have a favorable initial response to NIV, clinicians should strongly consider intubation without delay. When used appropriately, NIV improves patient outcomes and the efficiency of care. Although it is still used in only a select minority of patients with acute respiratory failure, it has assumed an important role in the therapeutic armamentarium. With technical advances and new evidence on its proper application, this role is likely to expand. References 1 Liesching T, Kwok H, Hill NS. Acute applications of noninvasive positive pressure ventilation. Chest 2003; 124: Brochard L, Isabey D, Piquet J, et al. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Engl J Med 1990; 323: Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993; 341: Kramer N, Meyer TJ, Meharg J, et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151: Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355: Dikensoy O, Ikidag B, Filiz A, et al. Comparison of noninvasive ventilation and standard medical therapy in acute hypercapnic respiratory failure: a randomised controlled study at a tertiary health centre in SE Turkey. Int J Clin Pract 2002; 56: Celikel T, Sungur M, Ceyhan B, et al. Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure. Chest 1998; 114: Ram FS, Picot J, Lightowler J, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004; 3:CD Keenan SP, Sinuff T, Cook DJ, et al. Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive pressure ventilation? A systematic review of the literature. Ann Intern Med 2003; 138: Bersten AD, Holt AW, Vedig AE, et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med 1991; 325: Lin M, Yang Y, Chiany H, et al. Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema: short-term results and long-term follow-up. Chest 1995; 107: Nava S, Carbone G, DiBattista N, et al. Noninvasive ventilation in cardiogenic pulmonary edema: a multicenter randomized trial. Am J Respir Crit Care Med 2003; 168: Crane SD, Elliott MW, Gilligan P, et al. Randomised controlled comparison of continuous positive airways pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema. Emerg Med J 2004; 21: Pang D, Keenan SP, Cook DJ, et al. The effect of positive airway pressure on mortality and the need for intubation in cardiogenic pulmonary edema. Chest 1998; 114: Rasanen J, Heikkila J, Downs J, et al. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary 718 Postgraduate Education Corner
9 edema. Am J Cardiol 1985; 55: Lin M, Chiang HT. The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. J Formos Med Assoc 1991; 90: Park M, Sangean MC, Volpe Mde S, et al. Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med 2004; 32: Masip J, Roque M, Sanchez B, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. JAMA 2005; 294: Winck JC, Azevedo LF, Costa-Pereira A, et al. Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema: a systematic review and metaanalysis. Crit Care 2006; 10:R69 20 Collins SP, Mielniczuk LM, Whittingham HA, et al. The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review. Ann Emerg Med 2006; 48: Ho KM, Wong K. A comparison of continuous and bi-level positive airway pressure non-invasive ventilation in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Crit Care 2006; 10:R Mehta S, Jay GD, Woolard RH, et al. Randomized prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med 1997; 25: Ferrer M, Esquinas A, Arancibia F, et al. Noninvasive ventilation during persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med 2003; 168: Nava S, Ambrosino N, Clini E, et al. Non-invasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: a randomized study. Ann Intern Med 1998; 128: Antonelli M, Conti G, Bufi M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA 2000; 283: Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, and acute respiratory failure. N Engl J Med 2001; 344: Meduri GU, Turner RE, Abou-Shala N, et al. Noninvasive positive pressure ventilation via face mask: first line intervention in patients with acute hypercapnic and hypoxemic respiratory failure. Chest 1996; 109: Meduri GU, Cook TR, Turner RE, et al. Noninvasive positive pressure ventilation in status asthmaticus. Chest 1996; 110: Fernandez MM, Villagra A, Blanch L, et al. Non-invasive mechanical ventilation in status asthmaticus. Intensive Care Med 2001; 27: Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bi-level positive airway pressure in acute asthmatic attack. Chest 2003; 123: Agarwal R, Malhotra P, Gupta D. Failure of NIV in acute asthma: case report and a word of caution. Emerg Med J 2006; 23:e9 32 Ram FS, Wellington S, Rowe B, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005; 1:CD Kindgen-Milles D, Muller E, Buhl R, et al. Nasal continuous positive airway pressure reduces pulmonary morbidity and length of stay following thoracoabdominal aortic surgery. Chest 2005; 128: Squadrone V, Coha M, Cerutti E, et al. Continuous positive airway pressure for treatment of postoperative hypoxemia. JAMA 2005; 293: Auriant I, Jallot A, Herve P, et al. Noninvasive ventilation reduces mortality in acute respiratory failure following lung resection. Am J Respir Crit Care Med 2001; 164: Clarke DE, Vaughan L, Raffin TA. Noninvasive positive pressure ventilation for patients with terminal respiratory failure: the ethical and economic cost of delaying the inevitable are too great. Am J Crit Care 1994; 3: Levy MM, Tanios MA, Nelson D, et al. Outcomes of patients with do-not- intubate orders treated with noninvasive ventilation. Crit Care Med 2004; 32: Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive-pressure ventilation reverses acute respiratory failure in select do-not-intubate patients. Crit Care Med. 2005; 33: Curtis RJ, Cook DJ, Sinuff T, et al. Noninvasive positive pressure ventilation in critical and palliative care settings: understanding the goals of therapy. Crit Care Med 2007 (in press) 40 Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998; 339: Ferrer M, Esquinas A, Leon M, et al. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003; 168: Ambrosino N, Foglio K, Rubini F, et al. Noninvasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success. Thorax 1995; 50: Honrubia T, Garcia Lopez F, Franco N, et al. Noninvasive vs. conventional mechanical ventilation for acute respiratory failure. Chest 2005; 128: Antonelli M, Conti G, Moro ML, et al. Predictors of failures of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 2001; 27: Jolliet P, Abajo B, Pasquina P, et al. Non-invasive pressure support ventilation in severe community-acquired pneumonia. Intensive Care Med 2001; 27: Confalonieri M, Potena A, Carbone G, et al. Acute respiratory failure in patients with severe community-acquired pneumonia. Am J Respir Crit Care Med 1999; 160: Antonelli M, Conti G, Esquinas A, et al. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med 2007; 35: Rana S, Hussam J, Gay P, et al. Failure of non-invasive ventilation in patients with acute lung injury: observational cohort study. Crit Care 2006; 10:R79 49 Blivet S, Philit F, Sab JM, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001; 120: Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest 2001; 119: Esteban A, Frutos-Vivar F, Ferguson ND, et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 2004; 350: Ferrer M, Valencia M, Nicolas JM, et al. Early noninvasive ventilation averts extubation failure in patients at high risk: a randomized trial. Am J Respir Crit Care Med 2006; 173: Nava S, Gregoretti C, Fanfulla F, et al. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients. Crit Care Med 2005; 33: CHEST / 132 / 2/ AUGUST,
10 54 Nava S, Navalesi P, Conti G. Time of non-invasive ventilation. Intensive Care Med 2006; 32: Gonzalez Diaz G, Carillo A, Perez P, et al. Noninvasive positive-pressure ventilation to treat hypercapnic coma secondary to respiratory failure. Chest 2005; 127: Scala R, Naldi M, Archinucci I, et al. Noninvasive positivepressure ventilation in patients with acute exacerbations of COPD and varying levels of consciousness. Chest 2005; 128: Confalonieri M, Garuti G, Cattaruzza MS, et al. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005; 25: Kwok H, McCormack J, Cece R, et al. Controlled trial of oronasal versus nasal mask ventilation in the treatment of acute respiratory failure. Crit Care Med 2003; 31: Tonnelier JM, Prat G, Nowak E, et al. Noninvasive continuous positive airway pressure ventilation using a new helmet interface: a case prospective pilot study. Intensive Care Med 2003; 29: Principi T, Pantanetti S, Catani F, et al. Noninvasive continuous positive airway pressure delivered by helmet in hematological malignancy patients with hypoxemic acute respiratory failure. Intensive Care Med 2004; 30: Antonelli M, Pennisi MA, Pelosi P, et al. Noninvasive positive pressure ventilation using a helmet in patients with acute exacerbation of chronic obstructive pulmonary disease. Anesthesiology 2004; 100: Cavaliere F, Conti G, Costa R, et al. Noise exposure during noninvasive ventilation with a helmet, a nasal mask, and a facial mask. Intensive Care Med 2004; 30: Ferguson GT, Gilmartin M. CO 2 rebreathing during BiPAP ventilatory assistance. Am J Respir Crit Care Med 1995; 151: Schettino GPP, Chatmongkolchart S, Hess D, et al. Position of exhalation port and mask design affect CO 2 rebreathing during noninvasive positive pressure ventilation. Crit Care Med 2003; 31: Saatci E, Miller DM, Sztell IM, et al. Dynamic dead space in face masks used with noninvasive ventilators: a lung model study. Eur Respir J 2004; 23: Vitacca M, Rubini F, Foglio K, et al. Noninvasive modalities of positive pressure ventilation improve the outcome of acute exacerbations of COLD patients. Intensive Care Med 1993; 19: Fernandez-Vivas M, Caturia-Such J, de la Rosa JG, et al. Noninvasive pressure support versus proportional assist ventilation in acute respiratory failure. Intensive Care Med 2003; 29: Gay PC, Hess DR, Hill NS. Noninvasive proportional assist ventilation for acute respiratory insufficiency: comparison with pressure support ventilation. Am J Respir Crit Care Med 2001; 164: Wysocki M, Richard JC, Meshaka P. Noninvasive proportional assist ventilation compared with noninvasive pressure support ventilation in hypercapnic acute respiratory failure. Crit Care Med 2002; 30: Mehta S, McCool FD, Hill NS. Leak compensation in positive pressure ventilators: a lung model study. Eur Respir J 2001; 17: Holland AE, Denehy L, Buchan CA, et al. Efficacy of a heated passover humidifier during noninvasive ventilation: a bench study. Respir Care 2007; 52: Lellouche F, Maggiore SM, Deye N, et al. Effect of the humidification device on the work of breathing during noninvasive ventilation. Intensive Care Med 2002; 28: L Her E, Deye N, Lellouche F, et al. Physiologic effects of noninvasive ventilation during acute lung injury. Am J Crit Care Med 2005; 172: Prinianakis G, Delmastro M, Carlucci A, et al. Effect of varying the pressurization rate during noninvasive pressure support ventilation. Eur Respir J 2004; 23: Sinuff T, Cook DJ, Randall J, et al. Evaluation of a practice guideline for noninvasive positive pressure ventilation for acute respiratory failure. Chest 2003; 123: Carlucci A, Richard JC, Wysocki M, et al. Noninvasive versus conventional mechanical ventilation. Am J Respir Crit Care Med 2001; 163: Doherty MJ, Greenstone MA. Survey of non-invasive ventilation (NIPPV) in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) in the UK. Thorax 1998; 53: Maheshwari V, Paioli D, Rothaar R, et al. Utilization of noninvasive ventilation in acute care hospitals. Chest 2006; 129: Demoule A, Girou E, Richard JC, et al. Increased use of noninvasive ventilation in French intensive care units. Intensive Care Med 2006; 32: Girou E, Brun-Buisson C, Taille S, et al. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA 2003; 290: Postgraduate Education Corner
NIV in acute hypoxic respiratory failure
All course materials, including the original lecture, are available as webcasts/podcasts at www.ers-education. org/niv2009.htm NIV in acute hypoxic respiratory failure Educational aims This presentation
More informationSurgery Grand Rounds. Non-invasive Ventilation: A valuable tool. James Cromie, PGY 3 8/24/09
Surgery Grand Rounds Non-invasive Ventilation: A valuable tool James Cromie, PGY 3 8/24/09 History of mechanical ventilation 1930 s: use of iron lung 1940 s: First NIV system (Bellevue Hospital) 1950 s:
More informationNoninvasive Ventilation: Non-COPD Applications
Noninvasive Ventilation: Non-COPD Applications NONINVASIVE MECHANICAL VENTILATION Why Noninvasive Ventilation? Avoids upper A respiratory airway trauma system lacerations, protective hemorrhage strategy
More informationAcute Applications of Noninvasive Positive Pressure Ventilation* Timothy Liesching, MD; Henry Kwok, MD, FCCP; and Nicholas S.
reviews Acute Applications of Noninvasive Positive Pressure Ventilation* Timothy Liesching, MD; Henry Kwok, MD, FCCP; and Nicholas S. Hill, MD, FCCP Noninvasive positive-pressure ventilation (NPPV) has
More informationNIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity
NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Use of NIV 1998-2010 50 45 40 35 30 25 20 15 10 5 0 1998
More informationNoninvasive positive-pressure ventilation in acute respiratory failure. Oscar Peñuelas MD, Fernando Frutos-Vivar MD, Andrés Esteban MD PhD
Noninvasive positive-pressure ventilation in acute respiratory failure Oscar Peñuelas MD, Fernando Frutos-Vivar MD, Andrés Esteban MD PhD DOI:10.1503/cmaj.060147 Abstract Noninvasive positive-pressure
More informationKeeping Patients Off the Vent: Bilevel, HFNC, Neither?
Keeping Patients Off the Vent: Bilevel, HFNC, Neither? Robert Kempainen, MD Pulmonary and Critical Care Medicine Hennepin County Medical Center University of Minnesota School of Medicine Objectives Summarize
More informationWhat is the next best step?
Noninvasive Ventilation William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center What is the next best step? 65 year old female
More informationDean R Hess PhD RRT, Jessica M Pang, and Carlos A Camargo Jr MD DrPH
Original Research A Survey of the Use of Noninvasive Ventilation in Academic Emergency Departments in the United States Dean R Hess PhD RRT, Jessica M Pang, and Carlos A Camargo Jr MD DrPH OBJECTIVE: To
More informationNon-invasive Positive Pressure Mechanical Ventilation: NIPPV: CPAP BPAP IPAP EPAP. My Real Goals. What s new in 2018? OMG PAP?
Non-invasive Positive Pressure Mechanical Ventilation: What s new in 2018? Geoffrey R. Connors, MD, FACP Associate Professor of Medicine University of Colorado School of Medicine Division of Pulmonary
More informationNon-invasive Ventilation
Non-invasive Ventilation 163 29 Non-invasive Ventilation AM BHAGWATI Artificial ventilatory support has became an integral component in the management of critically ill patients in the intensive care units.
More informationConcerns and Controversial Issues in NPPV. Concerns and Controversial Issues in Noninvasive Positive Pressure Ventilation
: Common Therapy in Daily Practice Concerns and Controversial Issues in Noninvasive Positive Pressure Ventilation Rongchang Chen Guangzhou Institute of Respiratory Disease as the first choice of mechanical
More informationNIV use in ED. Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH
NIV use in ED Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH Outline History & Introduction Overview of NIV application Review of proven uses of NIV History of Ventilation 1940
More informationPOLICY. Number: Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE. Authorization
POLICY Number: 7311-60-024 Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE Authorization [ ] President and CEO [ x ] Vice President, Finance and Corporate Services Source:
More informationEFFICACY OF BIPAP IN PATIENTS ADMITTED WITH HYPERCAPNIC RESPIRATORY FAILURE; AN EXPERIENCE AT A TERTIARY CARE HOSPITAL
ORIGINAL ARTICLE EFFICACY OF BIPAP IN PATIENTS ADMITTED WITH HYPERCAPNIC RESPIRATORY FAILURE; AN EXPERIENCE AT A TERTIARY CARE HOSPITAL Hussain Ahmad*, Saadia Ashraf*, Rukhsana Javed Farooqi*, Mukhtiar
More informationISPUB.COM. S Venkatram, S Rachmale, B Kanna, A Soni INTRODUCTION METHODS AND MATERIALS DESIGN SETTING INCLUSION CRITERIA
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 12 Number 1 Non-Invasive Positive Pressure Ventilation Compared To Invasive Mechanical Ventilation Among Patients With COPD Exacerbations In
More informationNoninvasive ventilation: Selection of patient, interfaces, initiation and weaning
CME article Johnson S, et al: Noninvasive ventilation Noninvasive ventilation: Selection of patient, interfaces, initiation and weaning Saumy Johnson, Ramesh Unnikrishnan * Email: ramesh.unnikrishnan@manipal.edu
More informationThe Role of Noninvasive Ventilation in the Ventilator Discontinuation Process
The Role of Noninvasive Ventilation in the Ventilator Discontinuation Process Dean R Hess PhD RRT FAARC Introduction NIV to Shorten the Length of Invasive Ventilation NIV to Prevent Extubation Failure
More informationNoninvasive ventilation in patients with do-not-intubate orders: medium-term efficacy depends critically on patient selection
Intensive Care Med (2007) 33:350 354 DOI 10.1007/s00134-006-0437-6 BRIEF REPORT Rafael Fernandez Francisco Baigorri Antonio Artigas Noninvasive ventilation in patients with do-not-intubate orders: medium-term
More informationCOMPLICACIONS DE LA VENTILACIÓ MECÀNICA NO INVASIVA
COMPLICACIONS DE LA VENTILACIÓ MECÀNICA NO INVASIVA Dr. Miquel Ferrer UVIIR, Servei de Pneumologia, Hospital Clínic, IDIBAPS, CibeRes, Barcelona. E- mail: miferrer@clinic.ub.es Barcelona, 3 de novembre
More informationEffect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order
ORIGINAL RESEARCH Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order Paolo Scarpazza 1 Cristoforo Incorvaia
More informationA study of non-invasive ventilation in acute respiratory failure
Original Research Article A study of non-invasive ventilation in acute respiratory failure Nilima Manohar Mane 1, Jayant L. Pednekar 2, Sangeeta Pednekar 3* 1 Consultant Physician and Diabetologist, Apollo
More informationNon-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome
708 Department of Respiratory Medicine, St James s University Hospital, Leeds LS9 7TF, UK P K Plant JLOwen M W Elliott Correspondence to: Dr P K Plant Paul.Plant@ gw.sjsuh.northy.nhs.uk Received 25 July
More informationGE Healthcare. Non Invasive Ventilation (NIV) For the Engström Ventilator. Relief, Relax, Recovery
GE Healthcare Non Invasive Ventilation (NIV) For the Engström Ventilator Relief, Relax, Recovery COPD is currently the fourth leading cause of death in the world, and further increases in the prevalence
More information176 Airway pressure release ventilation, biphasic positive airway pressure Continuous positive airway pressure Figure 3.23 Figure 7.
176 INTENSIVE CARE Airway pressure release ventilation, biphasic positive airway pressure Alveolar ventilation is achieved by the time-cycled switching between two levels of CPAP. Inspiratory and expiratory
More informationNon-invasive ventilation:
Glossary ARF: Acute respiratory failure CHF: Congestive heart failure COPD: Chronic obstructive pulmonary disease CPAP: Continuous positive airway pressure CPE: Cardiogenic pulmonary oedema DNI: Do not
More informationNON-INVASIVE VENTILATION. Lijun Ding 23 Jan 2018
NON-INVASIVE VENTILATION Lijun Ding 23 Jan 2018 Learning objectives What is NIV The difference between CPAP and BiPAP The indication of the use of NIV Complication of NIV application Patient monitoring
More informationNIV in hypoxemic patients
NIV in hypoxemic patients Massimo Antonelli, MD Dept. of Intensive Care & Anesthesiology Università Cattolica del Sacro Cuore Rome - Italy Conflict of interest (research grants and consultations): Maquet
More informationNon-Invasive Ventilation
Khusrav Bajan Head Emergency Medicine, Consultant Intensivist & Physician, P.D. Hinduja National Hospital & M.R.C. 112 And the Lord God formed man of the dust of the ground and breathed into his nostrils
More informationRecent advances in mechanical ventilation
The American Journal of Medicine (2005) 118, 584 591 REVIEW Recent advances in mechanical ventilation Carolyn S. Calfee, MD, a,b Michael A. Matthay, MD a,b,c a From the Cardiovascular Research Institute,
More informationThe Practitioner Le practicien
The Practitioner Le practicien The occasional acute application of continuous positive airway pressure 68 John Bosomworth, MD, CCFP, FCFP Princeton, BC Correspondence to: Dr. John Bosomworth, Box 867,
More informationN on-invasive ventilation (NIV) consists of mechanical
772 ORIGINAL ARTICLE Non-invasive ventilation as a first-line treatment for acute respiratory failure: real life experience in the emergency department C Antro, F Merico, R Urbino, V Gai... See end of
More informationNon-invasive ventilation for surgical patients with acute respiratory failure. Byoung Chul Lee, Kyu Hyouck Kyoung, Young Hwan Kim, Suk-Kyung Hong
J Korean Surg Soc 2011;80:390-396 DOI: 10.4174/jkss.2011.80.6.390 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Non-invasive ventilation for surgical patients
More informationNoninvasive Mechanical Ventilation in Children ศ.พญ.อร ณวรรณ พฤทธ พ นธ หน วยโรคระบบหายใจเด ก ภาคว ชาก มารเวชศาสตร คณะแพทยศาสตร โรงพยาบาลรามาธ บด
Noninvasive Mechanical Ventilation in Children ศ.พญ.อร ณวรรณ พฤทธ พ นธ หน วยโรคระบบหายใจเด ก ภาคว ชาก มารเวชศาสตร คณะแพทยศาสตร โรงพยาบาลรามาธ บด Noninvasive Mechanical Ventilation Provide support without
More informationBasics of NIV. Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC. Consultant, Critical Care Medicine Medanta, The Medicity
Basics of NIV Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Objectives: Definitions Advantages and Disadvantages Interfaces Indications Contraindications
More informationRecent Advances in Respiratory Medicine
Recent Advances in Respiratory Medicine Dr. R KUMAR Pulmonologist Non Invasive Ventilation (NIV) NIV Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive
More informationAlma Mater University of Bologna. Respiratory and Critical Care Sant Orsola Hospital, Bologna, Italy
Alma Mater University of Bologna Respiratory and Critical Care Sant Orsola Hospital, Bologna, Italy Conflict of Interest I have affiliations with, special interests, or have conducted business with the
More informationKeywords COPD, helmet, hypoxemic respiratory failure, immunocompromised, noninvasive ventilation
Critical Care February 2005 Vol 9 No 1 Antonelli et al. Review Clinical review: Noninvasive ventilation in the clinical setting experience from the past 10 years Massimo Antonelli 1, Mariano Alberto Pennisi
More informationAcute exacerbations are common in patients with
Predicting the Result of Noninvasive Ventilation in Severe Acute Exacerbations of Patients With Chronic Airflow Limitation* Antonio Antón, MD; Rosa Güell, MD; Juan Gómez, MD; José Serrano, MD; Abilio Castellano,
More informationDyspnea: Should we use BIPAP?
Dyspnea: Should we use BIPAP? Thomas R. Gildea MD, MS FCCP Head Section of Bronchoscopy Respiratory Institute Transplant Center Disclosure SuperDimension Inc. PI for single center study Others: Aeris,
More informationNON INVASIVE LIFE SAVERS. Non Invasive Ventilation (NIV)
Table 1. NIV: Mechanisms Of Action Decreases work of breathing Increases functional residual capacity Recruits collapsed alveoli Improves respiratory gas exchange Reverses hypoventilation Maintains upper
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. This online publication has been corrected. The corrected
More information2016 Year in Review: Noninvasive Ventilation
2016 Year in Review: Noninvasive Ventilation Thomas Piraino RRT Introduction NIV Compared With High-Flow Nasal Cannula Immunocompromised Patients Postextubation in Patients at Risk of Extubation Failure
More informationNIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
Introduction NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) Noninvasive ventilation (NIV) is a method of delivering oxygen by positive pressure mask that allows for the prevention or postponement of invasive
More informationPredictors of Successful Noninvasive Ventilation Treatment for Patients Suffering Acute Respiratory Failure
ORIGINAL ARTICLE Predictors of Successful Noninvasive Ventilation Treatment for Patients Suffering Acute Respiratory Failure Ming-Shian Lin 1, How-Ran Guo 2,3, Ming-Hua Huang 4, Cheng-Ren Chen 1, Chen-Long
More informationBi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients
Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients Objectives Describe nocturnal ventilation characteristics that may indicate underlying conditions and benefits of bilevel therapy for specific
More informationPrepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor
Mechanical Ventilation Prepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor 1 Definition Is a supportive therapy to facilitate gas exchange. Most ventilatory support requires an artificial airway.
More informationBilevel positive airway pressure nasal mask ventilation in patients with acute hypercapnic respiratory failure
Bilevel positive airway pressure nasal mask ventilation in patients with acute hypercapnic respiratory failure CK Chan, KS Lau, HC Fan, CW Lam The efficacy and complications of bilevel positive airway
More informationMechanical Ventilation Principles and Practices
Mechanical Ventilation Principles and Practices Dr LAU Chun Wing Arthur Department of Intensive Care Pamela Youde Nethersole Eastern Hospital 6 October 2009 In this lecture, you will learn Major concepts
More informationHigh Flow Oxygen Therapy in Acute Respiratory Failure. Laurent Brochard Toronto
High Flow Oxygen Therapy in Acute Respiratory Failure Laurent Brochard Toronto Conflicts of interest Our clinical research laboratory has received research grants for clinical research projects from the
More informationNoninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency
Eur Respir J 1998; 11: 1349 1353 DOI: 10.1183/09031936.98.11061349 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 0903-1936 Noninvasive pressure support
More informationUse of Noninvasive Positive-Pressure Ventilation on the Regular Hospital Ward: Experience and Correlates of Success
Use of Noninvasive Positive-Pressure Ventilation on the Regular Hospital Ward: Experience and Correlates of Success Samar Farha MD, Ziad W Ghamra MD, Edward R Hoisington RRT, Robert S Butler MSc, and James
More informationApplication of BiPAP through Endotracheal Tube in Comatose Patients with COPD Exacerbation
Original Article Application of BiPAP through Endotracheal Tube in Comatose Patients with COPD Exacerbation Nousheen Akhter 1, Nadeem Ahmed Rizvi 2 ABSTRACT Objective: To evaluate the effectiveness and
More informationBiLevel Pressure Device
PROCEDURE - Page 1 of 7 Purpose Scope Classes/ Goals Define indications and care settings for acute and chronic initiation of Noninvasive Positive Pressure Ventilation. Identify the role of Respiratory
More informationThe Rapid Shallow Breathing Index as a Predictor of Failure of Noninvasive Ventilation for Patients With Acute Respiratory Failure
Original Research The Rapid Shallow Breathing Index as a Predictor of Failure of Noninvasive Ventilation for Patients With Acute Respiratory Failure Katherine M Berg MD, Gerald R Lang RRT, Justin D Salciccioli,
More informationCharisma High-flow CPAP solution
Charisma High-flow CPAP solution Homecare PNEUMOLOGY Neonatology Anaesthesia INTENSIVE CARE VENTILATION Sleep Diagnostics Service Patient Support charisma High-flow CPAP solution Evidence CPAP therapy
More informationReferences for Chapter 23
references for chapter 23 1 References for Chapter 23 1 Drinker P, Shaw LA. An apparatus for the prolonged administration of artificial respiration: I. Design for adults and children. J Clin Invest 1929;7:229
More informationObjectives. Health care significance of ARF 9/10/15 TREATMENT OF ACUTE RESPIRATORY FAILURE OF VARIABLE CAUSES: INVASIVE VS. NON- INVASIVE VENTILATION
TREATMENT OF ACUTE RESPIRATORY FAILURE OF VARIABLE CAUSES: INVASIVE VS. NON- INVASIVE VENTILATION Louisa Chika Ikpeama, DNP, CCRN, ACNP-BC Objectives Identify health care significance of acute respiratory
More informationParamedic Rounds. Pre-Hospital Continuous Positive Airway Pressure (CPAP)
Paramedic Rounds Pre-Hospital Continuous Positive Airway Pressure (CPAP) Morgan Hillier MD Class of 2011 Dr. Mike Peddle Assistant Medical Director SWORBHP Objectives Outline evidence for pre-hospital
More informationThe Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic Review
CARDIOLOGY/ORIGINAL RESEARCH The Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic Review Sean P. Collins, MD, MSC Lisa M. Mielniczuk,
More informationNI 60. Non-invasive ventilation without compromise. Homecare Pneumology Neonatology Anaesthesia. Sleep Diagnostics Service Patient Support
NI 60 Non-invasive ventilation without compromise Homecare Pneumology Neonatology Anaesthesia INTENSIVE CARE VENTILATION Sleep Diagnostics Service Patient Support NI 60 Non-invasive ventilation without
More informationThe Egyptian Society of Chest Diseases and Tuberculosis. Egyptian Journal of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis (2012) 61, 95 101 The Egyptian Society of Chest Diseases and Tuberculosis Egyptian Journal of Chest Diseases and Tuberculosis www.elsevier.com/locate/ejcdt
More informationPapers. Abstract. Methods. Introduction. Josephine V Lightowler, Jadwiga A Wedzicha, Mark W Elliott, Felix S F Ram
Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis Josephine V Lightowler,
More information, OR 8.73 (95% CI
550 Thorax 2000;55:550 554 Department of Respiratory Medicine, St James s University Hospital, Leeds LS9 7TF, UK P K Plant JLOwen M W Elliott Correspondence to: Dr P K Plant email: mbriggs@alwoodley.u-net.com
More informationBenefits and risks of success or failure of noninvasive ventilation
Intensive Care Med (2006) 32:1756 1765 DOI 10.1007/s00134-006-0324-1 ORIGINAL Alexandre Demoule Emmanuelle Girou Jean-Christophe Richard Solenne Taille Laurent Brochard Benefits and risks of success or
More informationTest Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo
Instant dowload and all chapters Test Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo https://testbanklab.com/download/test-bank-pilbeams-mechanical-ventilation-physiologicalclinical-applications-6th-edition-cairo/
More informationMechanical ventilation: invasive versus noninvasive
Eur Respir J 2003; 22: Suppl. 47, 31s 37s DOI: 10.1183/09031936.03.00050403 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0904-1850 Mechanical ventilation:
More informationPAPER DE LA VNI EN LA RETIRADA DE LA VENTILACIÓ INVASIVA I FRACÀS D EXTUBACIÓ
PAPER DE LA VNI EN LA RETIRADA DE LA VENTILACIÓ INVASIVA I FRACÀS D EXTUBACIÓ Dr. Miquel Ferrer UVIIR, Servei de Pneumologia, Hospital Clínic, IDIBAPS, CibeRes, Barcelona. E- mail: miferrer@clinic.ub.es
More informationKeiko Nakazato 1,2*, Shinhiro Takeda 1,2, Keiji Tanaka 2 and Atsuhiro Sakamoto 1. Abstract
Nakazato et al. Journal of Cardiothoracic Surgery 2012, 7:41 RESEARCH ARTICLE Open Access Aggressive treatment with noninvasive ventilation for mild acute hypoxemic respiratory failure after cardiovascular
More informationRon Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.
Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist This program has been approved for 1 hour of continuing education credit. Course Objectives Identify at least four goals of home NIV Identify candidates
More informationWhat Is the Impact of Mildly Altered Consciousness on Acute Hypoxemic Respiratory Failure with Non-invasive Ventilation?
doi: 10.2169/internalmedicine.9355-17 Intern Med 57: 1689-1695, 2018 http://internmed.jp ORIGINAL ARTICLE What Is the Impact of Mildly Altered Consciousness on Acute Hypoxemic Respiratory Failure with
More informationERJ Express. Published on August 9, 2012 as doi: /
ERJ Express. Published on August 9, 2012 as doi: 10.1183/09031936.00076912 Extracorporeal membrane oxygenation in a non intubated patient with acute respiratory distress syndrome (ARDS) Olaf Wiesner, *
More informationEarly predictors of success of non-invasive positive pressure ventilation in hypercapnic respiratory failure
ORIGINAL ARTICLE Early predictors of success of non-invasive positive pressure ventilation in hypercapnic respiratory failure Col D Bhattacharyya*, Brig BNBM Prasad, SM, VSM, Surg Capt PS Tampi (Retd)
More informationThe use of proning in the management of Acute Respiratory Distress Syndrome
Case 3 The use of proning in the management of Acute Respiratory Distress Syndrome Clinical Problem This expanded case summary has been chosen to explore the rationale and evidence behind the use of proning
More informationNoninvasive Ventilation for Acute Respiratory Failure: A National Survey of Veterans Affairs Hospitals
Noninvasive Ventilation for Acute Respiratory Failure: A National Survey of Veterans Affairs Hospitals Gregory B Bierer MD and Guy W Soo Hoo MD MPH BACKGROUND: The utilization of noninvasive ventilation
More informationThe Art and Science of Weaning from Mechanical Ventilation
The Art and Science of Weaning from Mechanical Ventilation Shekhar T. Venkataraman M.D. Professor Departments of Critical Care Medicine and Pediatrics University of Pittsburgh School of Medicine Some definitions
More informationSystems differ in their ability to deliver optimal humidification
Average Absolute Humidity (mg H 2 O/L) Systems differ in their ability to deliver optimal humidification 45 Flows Tested 40 35 30 Optiflow Airvo 2 Vapotherm Vapotherm 5 L/min 10L/min 20L/min 30L/min 40L/min
More informationNoninvasive positive pressure ventilation improves
A Pilot Prospective, Randomized, Placebo-Controlled Trial of Bilevel Positive Airway Pressure in Acute Asthmatic Attack* Arie Soroksky, MD; David Stav, MD; and Isaac Shpirer, MD Study objective: Noninvasive
More informationSECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION
SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION DEMOGRAPHIC INFORMATION Given name Family name Date of birth Consent date Gender Female Male Date of surgery INCLUSION & EXCLUSION CRITERIA YES
More informationAcute noninvasive ventilation what s the evidence? Respiratory Medicine Update: Royal College of Physicians & BTS Thu 28 th January 2016
Acute noninvasive ventilation what s the evidence? Respiratory Medicine Update: Royal College of Physicians & BTS Thu 28 th January 2016 Annabel Nickol Consultant in Respiratory Medicine, Sleep & Ventilation
More informationOriginal Article. Bangladesh Crit Care J March 2013; 1: 3-7
; 1: 3-7 Original Article Outcome of NIV in Critical Care Setting: Experience from a Tertiary Care Center Md. Motiul Islam 1, Mirza Nazim Uddin 2, ARM Nooruzzaman 3, Raihan Rabbani 4, Ahmad Mursel Anam
More informationNon-invasive ventilation for acute respiratory disease
Published Online March 31, 2005 Non-invasive ventilation for acute respiratory disease M. W. Elliott St James s University Hospital, Beckett Street, Leeds LS9 7TF, UK Non-invasive ventilation (NIV) has
More informationTrial protocol - NIVAS Study
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery
More informationLandmark articles on ventilation
Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP
More informationEffective Health Care Program
Comparative Effectiveness Review Number 68 Effective Health Care Program Noninvasive Positive-Pressure Ventilation (NPPV) for Acute Respiratory Failure Executive Summary Background Acute respiratory failure
More informationEmergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE
Emergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE Indications for Vapotherm High Velocity Nasal Insufflation (Hi-VNI ) administration, the patient should be: Spontaneously
More informationLiberation from Mechanical Ventilation in Critically Ill Adults
Liberation from Mechanical Ventilation in Critically Ill Adults 2017 ACCP/ATS Clinical Practice Guidelines Timothy D. Girard, MD, MSCI Clinical Research, Investigation, and Systems Modeling of Acute Illness
More informationNon-invasive ventilation (NIV)
Non-invasive ventilation And the Lord God formed a man from the dust of the ground, and breathed into his nostrils the breath of life, and the man became a living being. B. Buyse (MD, PhD) Dept. of Pulmonology,
More informationIntroduction ORIGINAL. G. Conti M. Antonelli P. Navalesi. M. Rocco M. Bufi G. Spadetta. G. U. Meduri
Intensive Care Med (2002) 28:1701 1707 DOI 10.1007/s00134-002-1478-0 ORIGINAL G. Conti M. Antonelli P. Navalesi M. Rocco M. Bufi G. Spadetta G. U. Meduri Noninvasive vs. conventional mechanical in patients
More informationNIV in COPD Acute and Chronic Use
NIV in COPD Acute and Chronic Use Dr C M Chu MD, MSc, FRCP, FCCP Consultant Physician Department of Medicine & Geriatrics United Christian Hospital, Hong Kong NIV in COPD I. AE-COPD/ARF II. III. Weaning
More informationNasal ventilation in COPD exacerbations: early and late results of a prospective, controlled
Eur Respir J 2000; 15: 98±104 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Nasal ventilation in COPD exacerbations: early and late results
More informationWhere to perform noninvasive ventilation?
Eur Respir J 2002; 19: 1159 1166 DOI: 10.1183/09031936.02.00297202 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 SERIES 0NONINVASIVE VENTILATION
More informationPotential Conflicts of Interest
Potential Conflicts of Interest Patient Ventilator Synchrony, PAV and NAVA! Bob Kacmarek PhD, RRT Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 4-27-09 WSRC Received research
More informationI. Subject: Pressure Support Ventilation (PSV) with BiPAP Device/Nasal CPAP
I. Subject: Pressure Support Ventilation (PSV) with BiPAP Device/Nasal CPAP II. Policy: PSV with BiPAP device/nasal CPAP will be initiated upon a physician's order by Respiratory Therapy personnel trained
More informationRespiratory Failure how the respiratory physicians deal with airway emergencies
Respiratory Failure how the respiratory physicians deal with airway emergencies Dr Michael Davies MD FRCP Consultant Respiratory Physician Respiratory Support and Sleep Centre Papworth Hospital NHS Foundation
More informationEvaluation of the Effect of Prehospital Application of Continuous Positive Airway Pressure Therapy in Acute Respiratory Distress
BRIEF REPORT Evaluation of the Effect of Prehospital Application of Continuous Positive Airway Pressure Therapy in Acute Respiratory Distress G. Scott Warner, MD, FACP, FCCP Cullman Emergency Medical Services,
More informationCPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A randomized controlled trial
CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A randomized controlled trial Backgrounds Postoperative pulmonary complications are most frequent after cardiac surgery and lead to increased
More informationwith chronic obstructive pulmonary
A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome* Massimo Antonelli, MD; Giorgio Conti, MD; Antonio
More information